US | Recovery Tracker sees strong end to summer
The US Recovery Tracker exited the summer on a bright note. It rose 0.7ppts to 96.7 during the two weeks ended September 3 – the highest reading since late July. Despite downside risks from the Delta variant, the health situation is stabilizing, mobility is nearing its pre-pandemic level, and household spending is steady.
What you will learn:
- Record equity valuations continue to underpin looser financial conditions, but Covid-related supply constraints are limiting production. Employment took a breather on weaker small business payrolls and increased UI benefits searches.
- Regional recoveries stabilized in early September. The South posted its first gain since early July as Delta variant infections fell from their peak.
- New Covid cases remain elevated, but hospitalizations are declining and inoculations are steady at 900k/day. We expect the wider adoption of vaccine mandates following full FDA approval of the Pfizer vaccine will support increasing uptake.
Global Scenarios Service: Taiwan Tensions
Global economic prospects remain relatively subdued. The peak impact of past policy tightening has yet to be fully felt in the advanced economies and China is expected to underperform relative to consensus.Find Out More
Why a US year-end slowdown is still our base case
We still think that the US economy is headed for a slowdown at the turn of the year. Three factors will increasingly weigh on growth: the impact of past rate rises; the drag from fiscal policy; and less resilient household finances.Find Out More